All India Ophthalmological Society Financial Impact Survey on ophthalmology practice in India during COVID-19

Indian J Ophthalmol. 2021 Aug;69(8):2196-2201. doi: 10.4103/ijo.IJO_1116_21.

Abstract

Purpose: A survey was conducted by the All India Ophthalmological Society (AIOS) to document the initial coronavirus disease 2019 (COVID-19)-related financial impact on ophthalmology practice in India. It also assessed various measures taken by ophthalmologists and the possible role of AIOS in mitigating the economic crisis.

Methods: An online questionnaire-based cross-sectional survey was conducted among its registered members from July to August 2020. The prevalidated questionnaire contained 25 items related to the impact of COVID-19 on patient volume, the extent of financial distress faced by the ophthalmologists, and various proactive measures taken by them. All valid responses were tabulated and analyzed.

Results: Out of 1,026 respondents, more than 90% ophthalmologists faced a 25% or more reduction in outpatient and surgical volume. Nearly 59% reported that they can suffer from serious financial distress in near future due to COVID-19 pandemic-related losses. Those who are young (P < 0.0005), salaried (P < 0.0005), and practicing in private sector (P < 0.0005) and Tier 1 cities (P < 0.0005) are reported to be more vulnerable to become financially unstable. The major concerns were revenue losses (70%), preexisting debts (39%), and increased operating costs (27%). The majority (90%) believed that AIOS can help in alleviating the distress. There was also hesitancy regarding the adoption of teleophthalmology and home-based care.

Conclusion: COVID-19 has significantly affected the financial sustainability of ophthalmologists practicing in India. Identification of vulnerable groups and timely advocacy efforts by AIOS can help in mitigating this financial crisis.

Keywords: COVID-19; COVID-19 lockdown India; Coronavirus; SARS CoV-2; economic impact; financial distress; ophthalmologists; ophthalmology.

MeSH terms

  • COVID-19*
  • Cross-Sectional Studies
  • Humans
  • India / epidemiology
  • Ophthalmology*
  • Pandemics
  • SARS-CoV-2
  • Surveys and Questionnaires
  • Telemedicine*